PharmaResearch Co., Ltd. 214450
KRX · South Korea · Health Technology
KRW 314,500.00+4,000.00 (+1.29%)
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
REJURAN® COSMETICS, Korea's original PDRN brand from PharmaResearch, joined LAFC's Korean Heritage Night on Wednesday, Sept. 9, as a Proud Skincare Partner of the event, bringing K-Beauty into one of Los Angeles' most dynamic sports and cultural settings.
REJURAN COSMETICS, the premium derma-cosmetic brand developed by PharmaResearch, the South Korean pharmaceutical company behind the globally recognized REJURAN® PN-based skin booster available in more than 50 countries, will launch nationwide across all 148 Sephora Canada stores on Sept. 1, marking a significant milestone in the brand's continued expansion across North America.
PharmaResearch, the biopharmaceutical company behind REJURAN®, recently participated in Aesthetics 2026, an international aesthetic medicine symposium held in Sydney, Australia. The company delivered scientific presentations and clinical education programs focused on its flagship polynucleotide (PN)-based skin booster.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.